Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: the European evaLUation of pacliTaxel Eluting Stent (ELUTES) trial. - Wikidata - awgldk - TriplyDB

Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: the European evaLUation of pacliTaxel Eluting Stent (ELUTES) trial.

Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: the European evaLUation of pacliTaxel Eluting Stent (ELUTES) trial.

http://www.wikidata.org/entity/Q39674620

about

Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes High concentrations of drug in target tissues following local controlled release are utilized for both drug distribution and biologic effect: an example with epicardial inotropic drug delivery.Paclitaxel: new uses for an old drug.The safety and efficacy of aspirin and clopidogrel as a combination treatment in patients with coronary heart disease Drug-eluting stent: a review and update Mebendazole reduces vascular smooth muscle cell proliferation and neointimal formation following vascular injury in mice Percutaneous coronary intervention: recommendations for good practice and training.Neointimal hyperplasia associated with synthetic hemodialysis grafts.Are "treatment" bare metal stents superior to "control" bare metal stents? A meta-analytic approach Compound C inhibits vascular smooth muscle cell proliferation and migration in an AMP-activated protein kinase-independent fashion Implantation of paclitaxel-eluting stents in saphenous vein grafts: clinical and angiographic follow-up results from a multicentre study.Drug eluting stents in 2005.Dexamethasone-eluting stent: an anti-inflammatory approach to inhibit coronary restenosis.Clinical trials in restenosis with 7-hexanoyltaxol and paclitaxel-eluting stents.Sirolimus- or paclitaxel-eluting stents to prevent coronary artery restenosis.Preventing restenosis in early drug-eluting stent era: recent developments and future perspectives.Drug-eluting stents: a mechanical and pharmacologic approach to coronary artery disease.The drug-based pipeline against restenosis.Drug eluting stents: an updated meta-analysis of randomised controlled trials Drug-eluting stents: from evidence to policy.Technology Insight: an overview of research in drug-eluting stents.Cypher versus taxus: are there differences?First-in-man experience of self-expanding nitinol stents combined with drug-coated balloon in the treatment of femoropopliteal occlusive disease.Stents or surgery: the case for stents.Update on drug-eluting stents for prevention of restenosis.Restenosis related to percutaneous coronary intervention has been solved?Stent-based percutaneous coronary interventions in small coronary arteries.Coronary artery restenosis: vascular biology and emerging therapeutic strategies.Efficacy and safety of drug-eluting stents: current best available evidence.Progressive stent technologies: new approaches for the treatment of cardiovascular diseases.Delivery of large biopharmaceuticals from cardiovascular stents: a review Does the use of paclitaxel or rapamycin-eluting stent decrease further need for coronary-artery bypass grafting when compared with bare-metal stent?Long-term outcomes of patients receiving drug-eluting stents.Current status of off-pump coronary artery bypass surgery.Drug-eluting stents - what should be improved?Paclitaxel-eluting stents.Local drug delivery for treatment of coronary and peripheral artery disease.Long-term safety of drug-eluting stents.Coronary Stents: The Impact of Technological Advances on Clinical Outcomes.

P2860

Q24186681-570AB88C-0EBC-45E0-887F-20E917C627C2 Q24235466-06947370-0236-4627-AE8A-AE5C529C6DCC Q27310045-CEA3F41D-37E5-4EEE-A8C0-EFCC725AB742 Q27691306-12CF4E48-6204-491F-B577-6BFEB9B23147 Q28200757-2301A26B-F08C-4353-83D3-F10D3D129391 Q28219254-B2F315CC-C3BB-4702-B9EA-76C63EDBE956 Q28540222-130D1745-4451-4C5F-AA34-C50C92702EDC Q30479477-C352C8F8-081D-45EA-872A-D8803E6C3020 Q30492883-B918C99B-A795-47A6-B227-662C925A3386 Q34731151-7C9658C3-7956-4924-9BE6-0142094151DB Q35122850-F34AAA2C-9658-432B-8137-F3D1F8BFE7B4 Q35773286-35791857-2392-4F4C-8DBA-E5E58C43BB0E Q35808313-0A2EDBFF-354E-4FEF-92A0-31AFBCEB14C8 Q35879059-E0F0A25C-EB44-4399-9167-6146A8383366 Q35879094-77F0C7F8-6590-4360-9A5C-2F332381CE7C Q35925484-D7B702EF-28D1-4850-9FC9-7827C3AD8080 Q35938663-13479EB5-AB61-4488-82D5-E78955DCAC33 Q35945466-6F0A49AE-4A90-4290-9A5D-CB41410C8FFE Q36066019-FFF06AA0-3933-4C69-90FA-28EBF4ED00FF Q36282710-0F0149F0-9045-4207-900B-841C51E41BD6 Q36314909-366BEE34-2AE6-4A42-B0CD-8020F58FC719 Q36321778-AF4ACB29-0EE5-4EA6-9EC6-A1560E6037E6 Q36335170-148F52F0-02AC-4716-AE49-965A4B03F6DE Q36354843-5DAEDCEE-3D46-4ABB-A657-6B0B516F65E7 Q36360162-4D2ED7EA-C803-4938-9F04-BCEC64B1250F Q36375853-7CABBCBF-A887-4449-B22A-75603ADEE2FD Q36486769-9417442A-7A40-43F5-B28E-9E4B5ADA619A Q36555226-5507E88A-1C3C-404C-8858-A9C714CED93C Q36569798-29F05D6C-74CA-4E50-9A3A-183222ECE7A7 Q36639071-3BDF40C4-988B-4FDA-B868-16295155838A Q36640339-B23941C7-34A8-4268-B4C0-9F44B84A72EB Q36968009-3B75F255-3981-4EB0-806F-E254E5635B9C Q36997203-40BBF2C8-4C2A-414E-9D77-136CBF1C1022 Q37052543-7154A31C-EB86-4778-9EA3-E6E6107A8007 Q37125540-74578F74-9BDE-4165-94CF-7ED734C8E49C Q37144221-84AFDC62-C512-429E-AB02-CC7C36C434DD Q37608478-0AF8A134-AE04-4A2A-A263-3054E04C695B Q37765610-E1C53234-44F8-4651-B229-A3CE11EF03F9 Q38153786-0C1A1A1E-8B42-4462-8117-ADDF4AB55B17 Q38565074-5323B1FD-146B-4C40-99FA-9BAAAC7358A7

P2860

Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: the European evaLUation of pacliTaxel Eluting Stent (ELUTES) trial.

http://www.wikidata.org/entity/Q39674620

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Inhibition of restenosis with ...... Eluting Stent (ELUTES) trial.

@en

Inhibition of restenosis with ...... Eluting Stent (ELUTES) trial.

@nl

type

label

Inhibition of restenosis with ...... Eluting Stent (ELUTES) trial.

@en

Inhibition of restenosis with ...... Eluting Stent (ELUTES) trial.

@nl

prefLabel

Inhibition of restenosis with ...... Eluting Stent (ELUTES) trial.

@en

Inhibition of restenosis with ...... Eluting Stent (ELUTES) trial.

@nl

P1433

Q39674620-E6331639-CF48-4858-BE1D-B7B42B37AEC2

P1476

Q39674620-89CD23A0-1DCC-457D-ADE5-254C2A9098D2

P2093

Q39674620-077D4ED1-4E57-49CB-A614-EF7A229E1FE6

Q39674620-10090EFB-6593-4A26-A9D4-7C2C3A36DC9E

Q39674620-15CFCA1C-4377-4BD5-BD9F-B34DD837544F

Q39674620-313E1605-1467-409A-9586-CB7CD6A9179F

Q39674620-36A633CA-11EA-4A7E-8E4E-5E4B1DDECE31

Q39674620-3AD31535-B1E0-4E9B-97B2-F92888BE6F1C

Q39674620-4025D957-ADEF-4C1F-B75C-F7F0D9445794

Q39674620-50275A8C-42C5-4D70-9FBC-EA4AC25865D3

Q39674620-8829B248-C09F-41F0-A5D8-B8D460FCFC30

Q39674620-BB31AFDA-1AC8-4B84-A207-C20C563671EB

P304

Q39674620-63B66468-3F56-47C1-A113-4F133CCB425F

P31

Q39674620-27894772-AE41-4A1C-988E-8ACF472DC385

P356

Q39674620-FD9EEB8E-A4D0-4BDF-9244-8E8BE1C9BDE1

P407

Q39674620-FAFB9412-2118-446D-8735-5882DB2A8206

P433

Q39674620-70C40333-A0BD-4FEE-83F0-BEFFAC6E9510

P478

Q39674620-AB0D5E5C-EBE9-4A4A-B183-5DA2142764C9

P577

Q39674620-51A8DF31-5FFD-4509-BFDE-BB6A3C6E1D04

P698

Q39674620-DFF92B64-3D7D-46C2-A257-F5431CD48C70

P356

01.CIR.0000109694.58299.A0

P1433

P1476

Inhibition of restenosis with ...... Eluting Stent (ELUTES) trial.

@en

P2093

Alan W Heldman

http://www.w3.org/2001/XMLSchema#string

Albert E Raizner

http://www.w3.org/2001/XMLSchema#string

Amanda Stephens-Lloyd

http://www.w3.org/2001/XMLSchema#string

Anthony Gershlick

http://www.w3.org/2001/XMLSchema#string

Bernard Chevalier

http://www.w3.org/2001/XMLSchema#string

Christian Vrints

http://www.w3.org/2001/XMLSchema#string

Edoardo Camenzind

http://www.w3.org/2001/XMLSchema#string

Ivan De Scheerder

http://www.w3.org/2001/XMLSchema#string

Jean-Jacques Goy

http://www.w3.org/2001/XMLSchema#string

Jeffrey A Brinker

http://www.w3.org/2001/XMLSchema#string

P304

487-493

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/01.CIR.0000109694.58299.A0

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P577

2004-01-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14744971

http://www.w3.org/2001/XMLSchema#string